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Since the beginning of January 2008 sporadic cases of 
infections in humans caused by influenza A (H1N1) virus- 
resistant to available anti-influenza drugs have been 
reported worldwide [1,2]. The World Health Organization 
(WHO) in its report published on 18 March 2009 indicated 
that during weeks 1-4 (28 December 08-24 January 09), 
the level of overall influenza activity in the world 
increased. During this period, 1291 of 1362 A (H1N1) 
cases from 30 countries showed resistance to the antiviral 
drug osaltamivir. [3]. In Canada, United States of America, 
Japan, Republic of Korea, Hong Kong, France, Germany, 
Ireland, Sweden and United Kingdom the prevalence of 
oseltamivir resistance was reported to be more than 95% 
[3]. On 24 April WHO released the first alert indicating the 
occurrence of confirmed human cases of swine influenza 
(H1N1) in Mexico and the United States [4]. Subsequently 
the Centre for Disease Control and Prevention (CDC), in 
the United States confirmed that these human influenza 
cases were caused by a new strain of influenza A virus 
subtype (H1N1) [5]. 
A plethora of names was coined to describe the virus 
and outbreak ; "Swine flu", "Pig flu"," Mexican flu"," 
Mexican virus" , "H1N1 flu", "New flu", "North American 
influenza", and "Novel influenza A (H1N1)" to name a few 
[10]. "Swine flu names are evolving faster than the swine 
flu itself," says Martin Ensernick, the noted science 
reporter on the chaos over the nomenclature [13]. The 
WHO announced that they would refer to the new 
influenza virus as" Influenza A (H1N1)" or "Influenza A 
(H1N1) virus, human" as opposed to "swine flu" also to 
clear the misconception that eating pork products carried 
a risk of infection [14].  
 
 
With confirmation of sustained community level 
outbreaks in more countries- WHO Director-General, 
Margaret Chan, on 11 June 2009, decided to raise the 
alert level of influenza pandemic to Phase 6, the maximum 
level, signaling that the first pandemic of the twenty-first 
century was underway [6]. It was however stressed that 
the rise in pandemic alert level, was mainly attributed to 
the global spread of the virus, not its severity which can 
be mild, moderate, or severe. Influenza A viruses are 
medically important respiratory pathogens that cause both 
seasonal, endemic infections, and periodic, unpredictable 
pandemics [7]. The pandemic potential of Influenza A 
viruses have been ascribed to their host –range diversity, 
their genetic and antigenic diversity, and their ability to 
transform by constant genetic reassortment or 
spontaneous mutation [8].This can result in the 
emergence of novel progeny subtypes capable of both 
infecting and leading to sustained person-to- person 
transmission - to which there is little or no population 
immunity [7,8].  
 
Since 1700, there have been approximately a dozen 
influenza A virus pandemics; the past 100 years has 
witnessed three pandemics in 1918, 1957, and 1968 
(Table1) [9,10].The most famous and lethal outbreak of 
1918, the so called "Spanish flu ", is dubbed as " the 
greatest medical holocaust in recorded history" and killed 
up to 50 million people worldwide [11]. As of 26 June 
2009, the new influenza H1N1 virus has infected 55,867 
people, and 238 deaths have been reported from 108 
countries [12]. The United States has nearly half of the 
worlds swine influenza cases with nearly 21449 reported 
to CDC [12].   
 
Influenza viruses are enveloped negative-stranded RNA 
viruses with segmented genomes containing seven to 
eight gene segments and belong to the orthomyxoviridae 
family [15]. Distinguished by their internal and external 
proteins they are divided into three types (A, B and C). 
The three viruses differ in host range and pathogenicity 
[7]. Influenza B and C viruses are principally human 
pathogens. However, influenza A viruses infect a variety of 
warm-blooded animals, primarily aquatic birds and 
sometimes other animal hosts, including swine, horses, 
cats, dogs and humans [16]. The type A viruses are the 
most virulent human pathogens among the three influenza 
types - cause the most severe of disease, and are often 
implicated in annual epidemics and occasional pandemics 
[7]. The influenza A viruses are classified into subtypes on 
the basis of antigenic characterization of the 
hemagglutinin (HA) and neuraminidase (NA) surface 
glycoproteins that project from the virion. Sixteen HA and 
three NA subtypes are recognized in nature, but only four 
4HAs (H1, H2, H3, and H5) and 2NAs (N1 and N2) have 
been recorded thus far in epidemic and pandemic 
influenza A viruses [17]. 
 
There have been a lot of controversies and theories 
regarding the origins of the 2009 outbreak of new 
influenza A (H1N1). Did the virus have a natural origin? "A 
novel assembly of gene segments- by genetic exchange or 
spontaneous mutation"? Or, was it the product of a bio-
experimental lab? "It might have been created using eggs 
to grow viruses and make new vaccines, and could have 
been accidentally leaked to the general public" says 
Australian researcher and antiviral drug "Tamiflu" 
developer Adrain Gibbs [18]. However, emerging scientific 
data support the hypothesis of a "natural genesis" with 
domestic pigs in North America playing a central role in 
the generation and maintenance of this virus. Protein 
homology analysis of more than 400 protein sequences 
including polymerase proteins PB2, PB1, and PA, HA, 
matrix 1(MP1), nonstructural 1(NS1) encoded by the new 
influenza A (H1N1) virus as well as other homologous 
proteins from influenza viruses from past flu seasons 
revealed that this virus has a swine lineage [19].  
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Phylogenetic analysis confirms the genetic distinctness, 
that seems to be characteristic in pig-human interspecies 
transmission of influenza A [19]. Cluster analysis of 
nucleotide sequences of the present-and viruses 
previously identified in humans, birds and swine indicate 
that the 2009 pandemic influenza A (H1N1) virus is a 
genetic reassortment of at least two swine viruses from 
North America and Eurasia [20]. The viruses are 
antigenically distinct from seasonal human A (H1N1), and 
possess previously unrecognized molecular determinants 
that could be responsible for the rapid human -to- human 
transmission [21]. Using evolutionary analysis to estimate 
the timescale of the origins, Smith and his research team 
from The University of Hong Kong, report that -exchange 
of genetic material of swine lineages may have occurred 
several years before human emergence. Their results 
published in "Nature" suggest initial transmission to 
humans occurred several months before recognition of the 
outbreak, and that the multiple genetic ancestry of this 
influenza A (H1N1) is not indicative of an artificial origin 
[22].        
 
Table 1 Influenza pandemics of the 20th and 21st century 
Name of 
Pandemic  
Year  Interval  
years  
Deaths  Subtype 
involved  
Spanish flu  1918  18  40-80 
million  
H1N1  
Asian flu  1957  39  I  –1.5 
million  
H2N2  
 
Hong Kong 
flu  
1968  11  I  –1.5 
million  
H3N2  
 
Influenza 
A(H1N1)  
2009  11  238*  H1N1  
* As of 26 June 2009 
 
The biology of influenza A viruses is very complicated 
and pigs are thought to have a major role in inter-species 
transmission and generation of novel influenza strains 
[23,24]. Cells surface receptors of pig respiratory tract 
have oligosaccharides with sialic acid linked α2, 3 or α 2, 6 
to the penultimate galactose, which have a broad 
specificity for influenza viruses [25].The former are 
preferred by most avian influenza viruses and latter by 
human viruses. These receptors make the pigs susceptible 
for infection with both avian and human viruses-which is 
an important determinant of host range restriction, and 
also providing an environment for the adaptation of  avian 
HAs (HA anchors the virus to receptors) to acquire human 
α 2, 6 specificity [23,25]. Co-infection combined with co-
habitation of swine and poultry on small family farms 
worldwide has led to the "mixing vessel theory"- which 
suggests pigs may act as a mixing vessel for the 
reassortment of avian, swine and human viruses and 
generation of new "hybrid" pandemic viruses [23]. 
However, this threat posed by pigs seems to have been 
overlooked by policy makers and the scientific community- 
with their focus mainly on the prevention and control on 
avian A (H5N1) influenza [19]. 
 
Diagnostic tests for rapid detection and differentiation 
are urgently needed for early detection in suspected 
patients, prompt patient management, containing the 
disease, its surveillance, and allowing better pandemic 
preparedness. A limited number of standardized laboratory 
tests exist for the diagnosis of H1N1 infection. The WHO 
defines a probable clinical case as one that is confirmed by 
1. Specific reverse transcription –time polymerase chain 
reaction (RT-PCR) assays, 2. Isolation of the novel H1N1 
influenza virus, or 3. Detection of a fourfold rise of 
neutralization antibodies to this virus [26]. Detection of 
viral RNA by RT-PCR appears to be highly sensitive and 
can discriminate the novel H1N1 from other swine and H1 
subtype viruses; this is the  rapid test of choice for 
suspected influenza A(H1N1) illness [27]. Conventional 1-
step RT-RCR assay and 1-step quantitative real- time RT-
PCR assay to detect the present virus rapidly have been 
recently developed [27,28]. 
 
Prevention is better than cure. Vaccines are widely 
considered to be the first defense for providing advance 
protection against an influenza pandemic [29]. However, 
the effectiveness of influenza vaccines is arguable. The 
genes of the influenza viruses have high mutation rates 
and mutations that change amino acids in the antigenic 
portions of surface glycoproteins help to evade preexisting 
immunity." It would take years to produce an effective 
swine flu vaccine to meet global demands" says Greg 
Poland, head of the vaccine research program at the Mayo 
Clinic [30]. Neuraminadase inhibitors (oseltamivir and 
zanamivir), and M2 inhibitors (amantadine and 
rimantadine) are the currently available antiviral drugs to 
halt the spread of the virus in the body [31,32]. 
Development of new antiviral drugs is of paramount 
importance since currently circulating influenza virus 
strains have shown high frequencies of resistance to M2 
inhibitors and variable frequency of resistance to 
oseltamivir among A (H1N1) strains [33]. The enzymatic 
properties and crystal structures of oseltamivir-resistant 
influenza virus neuraminidase mutants has recently been 
elucidated-which may hasten the development of more 
effective antiviral drugs [34]. New antiviral agents 
including polymerase inhibitors (I-705) and an attachment 
inhibitor (DAS181) are also currently being developed 
[33]. 
 
Influenza A viruses represent a major health threat in 
both endemic and pandemic forms. "The virus writes the 
rules and this one, like all influenza viruses, can change 
the rules, without rhyme or reason, at any time," says. 
Margaret Chan, Director-General of WHO [6]. The 
management of the present influenza pandemic needs a 
rational and pragmatic approach-based on the expert 
advice and recommendations of influenza experts, 
virologists and public health officials. Lessons must be 
learnt from the previous epidemics and pandemics. The 
H1N1 pandemic of 1918 killed millions. Humanity as a 
whole needs to fight back now to avert a similar 
catastrophe. 
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